Krezalek Monika A, Alverdy John C
Department of Surgery, Center for Surgical Infection Research and Therapeutics Pritzker School of Medicine, University of Chicago, Chicago, Illinois, USA.
Curr Opin Clin Nutr Metab Care. 2016 Sep;19(5):347-352. doi: 10.1097/MCO.0000000000000299.
The purpose of this review is to highlight new research findings in the complex bidirectional crosstalk that occurs between the intestinal microbiome and the host immune system in the context of surgical recovery and outcomes.
Significant evidence has been generated emphasizing the central role of the intestinal microbiome on surgical outcomes such as wound healing, surgical site infections and anastomotic leak. Current preventive strategies, including the use of some parenteral antibiotics, may actually exacerbate the problem by selecting for drug-resistant pathogens.
A delicate balance exists between the human host and its microbial counterparts that is directly related to postsurgical healing. This balance can be easily altered in favor of the pathogen through perioperative and surgical interventions leading to intestinal dysbiosis and loss of colonization resistance. Current strategies to prevent infectious complications with the escalating use of broader and more powerful antibiotics are not an evolutionarily stable strategy. A more complete understanding of the ecological and molecular interactions of the host with its microbiome is necessary to uncover new therapeutic strategies that preserve the composition and function of the intestinal microbiome and constrain virulent pathogens through the course of surgical injury.
本综述旨在强调在手术恢复和预后背景下,肠道微生物群与宿主免疫系统之间复杂的双向串扰中的新研究发现。
已有大量证据强调肠道微生物群在手术预后(如伤口愈合、手术部位感染和吻合口漏)中的核心作用。当前的预防策略,包括使用一些胃肠外抗生素,实际上可能通过选择耐药病原体而使问题恶化。
人类宿主与其微生物群落之间存在一种微妙的平衡,这与术后愈合直接相关。通过围手术期和手术干预,这种平衡很容易向有利于病原体的方向改变,导致肠道生态失调和定植抗性丧失。随着越来越广泛和强效的抗生素不断升级使用,当前预防感染并发症的策略并非一种进化上稳定的策略。有必要更全面地了解宿主与其微生物群落的生态和分子相互作用,以发现新的治疗策略,这些策略可在手术损伤过程中维持肠道微生物群的组成和功能,并抑制致病病原体。